National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered Evaluation Assessment of Cardiac Events (PEACE)-Retrospective AMI Study, 2001, 2006, and 2011

BACKGROUND: Spironolactone, the only aldosterone antagonist available in China, improves outcomes in acute myocardial infarction (AMI) among patients with systolic dysfunction and either diabetes or heart failure (HF). However, national practice patterns in the use of spironolactone in China are unk...

詳細記述

保存先:
書誌詳細
出版年:J Am Heart Assoc
主要な著者: Guan, Wenchi, Murugiah, Karthik, Downing, Nicholas, Li, Jing, Wang, Qing, Ross, Joseph S, Desai, Nihar R, Masoudi, Frederick A, Spertus, John A, Li, Xi, Krumholz, Harlan M, Jiang, Lixin
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Ltd 2015
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599529/
https://ncbi.nlm.nih.gov/pubmed/26071031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.114.001718
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料